Showing results (71-80 of 201) with videos related to
Sort By:
Pageof 21
Nanoscale Horizons|June 29, 2023
Correction: Multiplexed molecular imaging with surface enhanced resonance Raman scattering nanoprobes reveals immunotherapy response in mice via multichannel image segmentationChrysafis Andreou, Konstantinos Plakas, Naxhije Berisha, et al.JCO Precision Oncology|September 14, 2020
BRCA Mutations, Homologous DNA Repair Deficiency, Tumor Mutational Burden, and Response to Immune Checkpoint Inhibition in Recurrent Ovarian CancerYing L Liu, Pier Selenica, Qin Zhou, et al.Scientific Reports|February 13, 2021
Targeting galectin-3 with a high-affinity antibody for inhibition of high-grade serous ovarian cancer and other MUC16/CA-125-expressing malignanciesMarina Stasenko, Evan Smith, Oladapo Yeku, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or bothEric Rios-Doria, Nadeem R Abu-Rustum, Gretchen Glaser, et al.Cancer|February 29, 2024
A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair-deficient and microsatellite instability-high endometrial cancersYing L Liu, Britta WeigeltInternational Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 29, 2024
2009 International Federation of Gynecology and Obstetrics (FIGO) stage IIIA endometrial cancer: oncologic outcomes based on involvement of adnexa, serosa, or bothEric Rios-Doria, Nadeem R Abu-Rustum, Gretchen Glaser, et al.Advances in Cancer Research|July 29, 2015
The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome MalignancyDanny N Khalil, Sadna Budhu, Billel Gasmi, et al.Journal of the National Cancer Institute|April 10, 2025
A working group report from the 2024 NCI/GCSC endometrial cancer clinical trials planning meeting: refining the approach to endometrial cancer in the immunotherapy eraCasey M Cosgrove, Dmitriy Zamarin, Jose R Conejo-Garcia, et al.JCO Precision Oncology|October 5, 2023
Phase IIa Study of PLX2853 in Gynecologic Cancers With Known ARID1A Mutation and Phase Ib/IIa Study of PLX2853/Carboplatin in Platinum-Resistant Epithelial Ovarian CancerLinda R Duska, Dmitriy Zamarin, Erica Hamilton, et al.Journal of the National Comprehensive Cancer Network : JNCCN|August 2, 2021
The Future of Parallel Tumor and Germline Genetic Testing: Is There a Role for All Patients With Cancer?Ying L Liu, Zsofia K StadlerPageof 21